Business
TGA proposes over-the-counter sales of CBD products – Small Caps
In a move that would appear to enthuse the ASX-listed cannabis stocks, the Therapeutic Goods Administration (TGA) has announced an interim decision to reclassify cannabidiol (CBD) products so they can be purchased over the counter at pharmacies.
In a move that would appear to enthuse the ASX-listed cannabis stocks, the Therapeutic Goods Administration (TGA) has announced an interim decision to reclassify cannabidiol (CBD) products so they can be purchased over the counter at pharmacies.
The TGAs provisional ruling entails the down-scheduling of low dose CBD products from Schedule 4 to Schedule 3 of the Poisons Standard. This means companies can apply to register their applicable products to be available through a pharmacist, without th…
-
Noosa News14 hours agoGippsland vegetable farm accused of underpaying migrant workers
-
General15 hours agoFour escape injury after jumping from three-storey unit on fire in Newcastle
-
Noosa News15 hours agoThe Best Things to Do in Brisbane This New Year’s Eve
-
Noosa News19 hours agoMary River cod thriving in Brisbane River catchment, century after relative went extinct